The second major direction for development in cardiac critical care for CS patients is represented by the efforts to implement appropriate logistics for reducing time de-
present one of the worst outcomes in the field of cardiac critical care, with mortality rates reported as high as 45-50% even in the presence of the most modern facilities for advanced cardiac support. 1 The main recent directions of development in the field of emergency care for critical patients with CS and AMI are represented by: the change introduced by the new European recommendations regarding the revascularization of culprit lesions only in patients with AMI and CS, the implementation of regional networks for reducing time delays from symptom onset to revascularization, and the use of modern equipment for advanced cardiac support. [1] [2] [3] The first major change in the therapeutic strategy for CS-AMI patients is related to the recent change in the 
